Structures by: Rodi K. Y.
Total: 11
4,7,10-Trioxa-1,13-diazatricyclo[11.6.3.0^14,19^]icosa-14,16,18-triene- 20,22-dione
C17H22N2O5
Acta Crystallographica Section E (2007) 63, 8 o3494-o3494
a=11.786(3)Å b=8.092(2)Å c=18.062(5)Å
α=90.00° β=103.692(17)° γ=90.00°
3-Allyl-1,5-dibenzyl-1,5-benzodiazepine-2,4-dione
C26H24N2O2
Acta Crystallographica Section E (2009) 65, 12 o3150
a=9.2603(4)Å b=14.0037(6)Å c=16.2249(7)Å
α=90.00° β=91.9960(10)° γ=90.00°
Ethyl 2-{4-[(1,5-dibenzyl-2,4-dioxo-2,3,4,5-tetrahydro-1<i>H</i>-1,5- benzodiazepin-3-yl)methyl]-1<i>H</i>-1,2,3-triazol-1-yl}acetate
C30H29N5O4
Acta Crystallographica Section E (2010) 66, 1 o126
a=14.2015(5)Å b=10.9337(4)Å c=17.9368(6)Å
α=90.00° β=95.699(2)° γ=90.00°
6-Bromo-1-[2-(2-oxo-1,3-oxazolidin-3-yl)ethyl]-1<i>H</i>- imidazo[4,5-<i>b</i>]pyridin-2(3<i>H</i>)-one
C11H11BrN4O3
Acta Crystallographica Section E (2010) 66, 2 o456
a=27.0174(11)Å b=6.0141(2)Å c=16.6121(6)Å
α=90.00° β=110.343(2)° γ=90.00°
3-[(1-Benzyl-1<i>H</i>-1,2,3-triazol-4-yl)methyl]-1,5-dimethyl- 1,5-benzodiazepine-2,4-dione
C21H21N5O2
Acta Crystallographica Section E (2010) 66, 3 o632
a=8.3380(3)Å b=9.1033(3)Å c=13.4796(4)Å
α=95.385(2)° β=107.840(2)° γ=101.768(2)°
3-[(1-Benzyl-1<i>H</i>-1,2,3-triazol-5-yl)methyl]-1,5-dimethyl- 1,5-benzodiazepine-2,4-dione monohydrate
C21H21N5O2,H2O
Acta Crystallographica Section E (2010) 66, 3 o633
a=9.60020(10)Å b=11.9497(2)Å c=17.0860(2)Å
α=90.00° β=92.5270(10)° γ=90.00°
1,3-Dibenzyl-6-bromo-1<i>H</i>-imidazo[4,5-<i>b</i>]pyridin-2(3<i>H</i>)-one
C20H16BrN3O
Acta Crystallographica Section E (2010) 66, 4 o754
a=9.16270(10)Å b=25.5071(3)Å c=8.06290(10)Å
α=90.00° β=115.5710(10)° γ=90.00°
4-Benzyl-6-bromo-2-(4-methoxyphenyl)-4<i>H</i>-imidazo[4,5-<i>b</i>]pyridine monohydrate
C20H16BrN3O,H2O
Acta Crystallographica Section E (2010) 66, 4 o947
a=10.5924(2)Å b=5.45440(10)Å c=31.7444(7)Å
α=90.00° β=100.2920(10)° γ=90.00°
1,3-Diallyl-5-chloro-1<i>H</i>-benzimidazol-2(3<i>H</i>)-one
C13H13ClN2O
Acta Crystallographica Section E (2011) 67, 2 o520
a=7.88310(10)Å b=15.2481(3)Å c=10.3593(2)Å
α=90.00° β=93.0560(10)° γ=90.00°
5-Nitro-1-<i>n</i>-octyl-1<i>H</i>-benzimidazol-2(3<i>H</i>)-one
C15H21N3O3
Acta Crystallographica Section E (2011) 67, 3 o558
a=4.9997(3)Å b=11.4942(6)Å c=13.8739(7)Å
α=74.214(3)° β=79.637(4)° γ=84.108(4)°
1-<i>n</i>-decyl-5-nitro-1<i>H</i>-benzimidazol-2(3<i>H</i>)-one
C17H25N3O3
Acta Crystallographica Section E (2011) 67, 3 o613
a=5.4933(2)Å b=10.3063(4)Å c=16.1655(6)Å
α=106.504(2)° β=98.545(2)° γ=96.809(2)°